How One Company Expects to Dominate Corporate Lunches

In India, the foodtech industry on fire right now—and Swiggy has become a major player. To stay relevant, the foodtech innovator is experimenting with B2B segment services by launching a pilot program for B2B food aggregation.

Swiggy Café started three months ago, is digitizing corporate cafeterias and being tested at two locations in Bengaluru representing the corporate sector.

Swiggy Café, reportedly still in development and looking to use their program as part of an overall larger business plan, gives users an app to order lunch from certain cafeterias in corporate hubs and receive notification when it is ready.

The idea is to cut wait times and improve efficiency during the lunch rush. The service is currently being used a few hundred times per day. Swiggy’s larger service, which offers food delivery, is currently handling more than 650,000 orders per day.

According to TechCrunch.com, the B2B food delivery arena is one of the largest untapped areas in the corporate world. While consumers have services such as Amazon and Instacart vying for our business, one area—the food and ingredient delivery for businesses—is still greatly underserved. This market is attention and capital starved and the industry is far behind where it could be, as result. One example is the food-preparation facilities and the challenges they face getting the ingredients to cook the food that consumers crave.

Another company ripe for the B2B market are those like Accomplice, whose apps coordinate ridesharing and food ordering. Already used in the B2C market, businesses also make a good market for these aggregator apps. They allow employees to save money for their employers and companies to save money for their clients. This is particularly true in situations in which travel and food expenses are reimbursed, as it provides a single platform form which to do business in a more cost-effective and time-efficient manner.

Accomplice Founder and CEO Hani Samaan wants to expand his presence throughout the U.S. and outside of America’s borders. Meanwhile, great news is reported for Swiggy as well—spending on food and business in the B2B space alone is estimated to reach $14 billion in India in 2018 with the sector growing at 15 percent per annum.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More